Conformis Revenue and Competitors
Estimated Revenue & Valuation
- Conformis's estimated annual revenue is currently $300M per year.
- Conformis's estimated revenue per employee is $1,020,408
- Conformis's total funding is $523.3M.
Employee Data
- Conformis has 294 Employees.
- Conformis grew their employee count by -8% last year.
Conformis's People
Name | Title | Email/Phone |
---|---|---|
1 | Area VP | Reveal Email/Phone |
2 | Area VP | Reveal Email/Phone |
3 | SVP Engineering | Reveal Email/Phone |
4 | VP, Business Development and Strategy | Reveal Email/Phone |
5 | VP, Human Resources & Imaging | Reveal Email/Phone |
6 | VP, International Sales & Marketing | Reveal Email/Phone |
7 | SVP Quality and Regulatory Affairs | Reveal Email/Phone |
8 | Chief Technology Officer | Reveal Email/Phone |
9 | Associate Director, Qualty Systems | Reveal Email/Phone |
10 | Director, Customer Support | Reveal Email/Phone |
Conformis Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 46583 | -5% | N/A | N/A |
What Is Conformis?
ConforMIS, Inc. is a privately held company incorporated in 2004 that develops and commercializes medical devices for treatment of osteoarthritis and joint damages. Our mission is to provide best-in-class, patient-specific implants and instrumentation that minimize the trauma and scarring, and improve the limited reproducibility often associated with traditional orthopedic implant surgery.
keywords:Biotechnology, Healthcare$523.3M
Total Funding
294
Number of Employees
$300M
Revenue (est)
-8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Conformis News
Aetna had argued Conformis tossed in state law tort claims "for good measure." The lower court sided with Aetna, dismissing the ERISA claims in...
BILLERICA, Mass., April 11, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today it will release its financial results...
Conformis is a medical technology company focused on advancing orthopedic patient care and creating a world without joint pain. Its product...
BILLERICA, Mass., Aug. 18, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) today announced the first procedure with the new Conformis Identity Imprint knee replacement system. Identity Imprint, available in both cruciate retaining (CR) and posterior stabilized (PS) implants, utilizes a p ...
BILLERICA, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today that Mark Augusti, Chief Executive Officer, and Bob Howe, Chief Financial Officer, will participate a ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $75.6M | 336 | 4% | N/A |
#2 | $93.4M | 372 | 6% | N/A |
#3 | $144M | 374 | 59% | N/A |
#4 | $132.8M | 590 | 15% | N/A |
#5 | $183.9M | 591 | 4% | $124.9M |